215 related articles for article (PubMed ID: 16886819)
1. US regulation of Advertising and promotional materials.
Donawa M
Med Device Technol; 2006 May; 17(4):26-8. PubMed ID: 16886819
[TBL] [Abstract][Full Text] [Related]
2. Advertising and promotion of medical devices.
Portnoy S
J Health Law; 2006; 39(2):265-82. PubMed ID: 17002234
[TBL] [Abstract][Full Text] [Related]
3. Understanding US labelling requirements.
Donawa M
Med Device Technol; 2005 Sep; 16(7):21-3. PubMed ID: 16259155
[TBL] [Abstract][Full Text] [Related]
4. Medical device labeling and advertising: an overview.
Basile EM; Armentrout E; Reeves KN
Food Drug Law J; 1999; 54(4):519-33. PubMed ID: 11824451
[TBL] [Abstract][Full Text] [Related]
5. Medical device reporting: another final rule, Part I.
Donawa M
Med Device Technol; 2000 Mar; 11(2):40-2. PubMed ID: 10915493
[TBL] [Abstract][Full Text] [Related]
6. Differing definitions of manufacturer.
Donawa ME
Med Device Technol; 1998; 9(6):14-7. PubMed ID: 10182120
[TBL] [Abstract][Full Text] [Related]
7. Regulating pharmaceutical advertising: what will work?
Shapiro MF
CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416
[TBL] [Abstract][Full Text] [Related]
8. US importer and distributor requirements.
Donawa M
Med Device Technol; 2005 Jun; 16(5):25-7. PubMed ID: 15984543
[TBL] [Abstract][Full Text] [Related]
9. Foreign Establishment Registration and United States agent requirements.
Nolte CJ; McNamara-Cullinane M
Med Device Technol; 2002 Dec; 13(10):32-3. PubMed ID: 12575528
[TBL] [Abstract][Full Text] [Related]
10. Understanding government regulation of the marketing and advertising of medical devices, drugs, and biologics: the challenges of the Internet.
Reichertz PS
Food Drug Law J; 1997; 52(3):303-8. PubMed ID: 10343029
[No Abstract] [Full Text] [Related]
11. New US agent requirements.
Donawa M
Med Device Technol; 2002; 13(1):35-7. PubMed ID: 11921780
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-18. PubMed ID: 18345557
[No Abstract] [Full Text] [Related]
13. How the laws govern advertising and promotional allowances given by suppliers.
Decker R
Hosp Mater Manage; 1992 Jan; 17(1):22-3. PubMed ID: 10116617
[TBL] [Abstract][Full Text] [Related]
14. Useful US guidance on device software.
Donawa M
Med Device Technol; 2005 Dec; 16(10):18-20. PubMed ID: 16419920
[TBL] [Abstract][Full Text] [Related]
15. How should FDA regulate prescription drug promotion on the Internet?
Opderbeck DW
Food Drug Law J; 1998; 53(1):47-61. PubMed ID: 11795336
[TBL] [Abstract][Full Text] [Related]
16. When ads trump evidence: is direct-to-consumer advertising leading practice?
Nelson R
Am J Nurs; 2007 Oct; 107(10):25-6. PubMed ID: 17895720
[No Abstract] [Full Text] [Related]
17. Organising European technical documentation to avoid duplication.
Donawa M
Med Device Technol; 2006 Apr; 17(3):29-31. PubMed ID: 16736662
[TBL] [Abstract][Full Text] [Related]
18. Meeting European and US requirements for design and development documentation, Part II.
Donawa ME
Med Device Technol; 1996 Dec; 7(10):10-5. PubMed ID: 10164052
[TBL] [Abstract][Full Text] [Related]
19. Final FDA inspection manual.
Donawa M
Med Device Technol; 2001 Apr; 12(3):29-32. PubMed ID: 11547684
[TBL] [Abstract][Full Text] [Related]
20. Striving for quality use of medicines: how effective is Australia's ban on direct-to-consumer prescription medicine advertising?
Brown S
J Law Med; 2009 Feb; 16(4):666-83. PubMed ID: 19297873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
